-
World Plastic Surgery Day: A Wound Is Never ‘Just a Wound’
By Dr. Aditya Patil, Lead Consultant – Plastic Surgery, KIMS Hospitals, Mahadevapura, Bengaluru A wound may seem like a simple…
-
Months of Unexplained Fainting Leads to Discovery of Rare Brain Condition; Manipal Hospital Dhakuria Successfully Treats Patient with Advanced Minimally Invasive Procedure
Mumbai/Kolkata, July 15: Doctors at Manipal Hospital, Dhakuria successfully diagnosed and treated a rare neurological condition called Idiopathic Intracranial Hypertension (IIH) (which is a is a rare neurological disorder in which the pressure inside…
-
Forus Health Launches FH eyepal, a Connected Digital Eye Clinic Designed to Expand Access to Comprehensive Eye Care
Bengaluru, July 13: Forus Health, a leading health technology company focused on transforming eye care through innovation, has announced the launch of FH Eyepal, a portable Digital Eye Clinic that enables healthcare providers…
-
Assam Budget 2026 Prioritises Youth, Infrastructure and Healthcare Expansion
Guwahati, July 10: The Assam government has presented a budget focused on employment generation, infrastructure development, healthcare improvement, and overall…
-
High-Alcohol Medicines Under New Regulatory Watch; Licensing Rules Proposed
New Delhi, July 10: The government has announced that formulations containing high levels of alcohol will require appropriate licences and…
-
Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
Milan, Italy, July 08 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder. The findings, published in the Journal of Hepatology, show that a single systemic administration of a lentiviral vector encoding the MMUT gene led to sustained improvements in disease features in a validated mouse model of MMA, with effects lasting for the average lifespan of laboratory mice. Since the mice were treated when young, the study supports the durability of the gene therapy through postnatal growth and maturation of the liver. MMA is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme that plays a critical role in the body’s metabolism of food. Its absence results in the accumulation of toxic metabolites that lead to recurrent metabolic crises, growth failure, neurological impairment, and multi-organ damage. In the study, researchers also treated mice with a dose containing an optimized MMUT transgene, thereby improving therapeutic efficacy. In the same mouse model of MMA, this…
-
MP Expands Digital Healthcare Reach Under Ayushman Bharat Mission
Bhopal, July 8: The Madhya Pradesh Government is working to expand digital healthcare services to the remotest parts of the…
-
IIM Lucknow Study Identifies Key Factors for Strengthening India’s Medical Tourism Appeal
Lucknow, July 8: Researchers from Indian Institute of Management Lucknow and Fortis Hospital, Delhi, have conducted a study examining how cultural sensitivity, communication, and expectation management…
-
Cashless Healthcare Scheme Brings New Medical Benefits for UP Teachers and Education Staff
Lucknow, July 8: The Uttar Pradesh government has launched a new cashless healthcare scheme aimed at providing easier and more…
-
Navi Mumbai Airport Approved for Import of Medicines
New Delhi, July 8: The Government has approved Navi Mumbai International Airport as an authorised point for importing medicines into…